Analytical Data
-
基因名
Scyb11
- Application
-
别名
Interferon-inducible T-cell alpha chemoattractant ;I-TACSmall-inducible cytokine B11
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9JHH5
-
表达区间
22-98aa
-
分子量
12.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Scyb11, a member of the scylla family of proteins, has garnered attention due to its potential role in various biological processes and its applications in biotechnology and medicine. Research into Scyb11 has revealed its involvement in crucial cellular functions, including cell signaling, stress responses, and regulation of gene expression. The recombinant production of Scyb11 protein has become essential for studying its structural and functional properties, which are vital for understanding its mechanism of action. The use of recombinant DNA technology allows for the efficient expression of Scyb11 in various host organisms, facilitating large-scale production and subsequent purification of the protein. This enables researchers to conduct detailed biochemical assays, structural analyses, and functional experiments to elucidate the protein's role in cellular processes. Moreover, insights gained from Scyb11 research could lead to the development of novel therapeutic strategies for diseases linked to dysregulation of the pathways involving this protein. As such, the exploration of Scyb11 as a recombinant protein not only advances fundamental biology but also holds promise for practical applications in drug development and biotechnological innovations. Overall, understanding Scyb11's properties and functions could contribute significantly to the broader fields of molecular biology and therapeutics.
